Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in inoperable CTEPH (China, Phase II)
CTR20140738Phase 2Completed
- Sponsor
- Tigermed
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of macitentan in chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Tigermed. Started Jul 2015; status: completed.
02
Drugs
macitentan
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on CTR20140738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140738.